Views & Analysis SMA Awareness Month: How pharma and digital solutions can im... Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.